IGM Biosciences, Inc. (IGMS) has a consensus analyst rating of Hold, based on 18 analysts covering the stock. Of those, 8 recommend buying, 10 recommend holding, and 0 recommend selling.
The analyst consensus price target for IGMS is $1.75, representing a +37.8% upside from the current price of $1.27. Price targets range from a low of $1.50 to a high of $2.00.
